143 related articles for article (PubMed ID: 33810944)
21. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
[TBL] [Abstract][Full Text] [Related]
22. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway.
Niu HQ; Zhao WP; Zhao XC; Luo J; Qin KL; Chen KL; Li XF
Int Immunopharmacol; 2018 Aug; 61():45-53. PubMed ID: 29803913
[TBL] [Abstract][Full Text] [Related]
23. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
[TBL] [Abstract][Full Text] [Related]
24. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway.
Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW
Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL.
Xing R; Zhang Y; Li C; Sun L; Yang L; Zhao J; Liu X
Int J Mol Med; 2016 Oct; 38(4):1125-34. PubMed ID: 27599586
[TBL] [Abstract][Full Text] [Related]
26. CYT387 Inhibits the Hyperproliferative Potential of Fibroblast-like Synoviocytes via Modulation of IL-6/JAK1/STAT3 Signaling in Rheumatoid Arthritis.
Srivastava S; Samarpita S; Ganesan R; Rasool M
Immunol Invest; 2022 Aug; 51(6):1582-1597. PubMed ID: 34704880
[TBL] [Abstract][Full Text] [Related]
27. Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis.
Dinesh P; Rasool M
Cytokine; 2018 Jun; 106():54-66. PubMed ID: 29549724
[TBL] [Abstract][Full Text] [Related]
28. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H
Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401
[TBL] [Abstract][Full Text] [Related]
29. An herbal formula inhibits STAT3 signaling and attenuates bone erosion in collagen-induced arthritis rats.
Chen YJ; Wu JY; Leung WC; Liu YX; Fu XQ; Zhu JQ; Wu Y; Chou JY; Yin CL; Wang YP; Wang XQ; Bai JX; Wu ZZ; Yu ZL
Phytomedicine; 2020 May; 76():153254. PubMed ID: 32531698
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study.
Chen Z; Cheng Z; Tang Z; Li M; Tang X; Zhang H; Sun L
Clin Exp Rheumatol; 2023 Nov; 41(11):2151-2161. PubMed ID: 36995338
[TBL] [Abstract][Full Text] [Related]
31. Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
Sprangers S; Schoenmaker T; Cao Y; Everts V; de Vries TJ
J Cell Physiol; 2016 Jun; 231(6):1249-60. PubMed ID: 26491867
[TBL] [Abstract][Full Text] [Related]
32. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
33. Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells.
Park KH; Gu DR; So HS; Kim KJ; Lee SH
J Dent Res; 2015 Dec; 94(12):1676-83. PubMed ID: 26350961
[TBL] [Abstract][Full Text] [Related]
34. TWEAK promotes osteoclastogenesis in rheumatoid arthritis.
Park JS; Kwok SK; Lim MA; Oh HJ; Kim EK; Jhun JY; Ju JH; Park KS; Park YW; Park SH; Kim HY; Cho YG; Cho ML
Am J Pathol; 2013 Sep; 183(3):857-67. PubMed ID: 23845567
[TBL] [Abstract][Full Text] [Related]
35. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Cho ML; Lee SH
PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998
[TBL] [Abstract][Full Text] [Related]
36. Dual Effect of Cyanidin on RANKL-Induced Differentiation and Fusion of Osteoclasts.
Dou C; Li J; Kang F; Cao Z; Yang X; Jiang H; Yang B; Xiang J; Xu J; Dong S
J Cell Physiol; 2016 Mar; 231(3):558-67. PubMed ID: 25545964
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK
Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876
[TBL] [Abstract][Full Text] [Related]
38. CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts.
Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Ahmad I; Tetali C; Sweiss N; Amin MA; Zomorrodi RK; Shahrara S
Eur J Immunol; 2021 Apr; 51(4):903-914. PubMed ID: 33347617
[TBL] [Abstract][Full Text] [Related]
39. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
40. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis.
Moon YM; Yoon BY; Her YM; Oh HJ; Lee JS; Kim KW; Lee SY; Woo YJ; Park KS; Park SH; Kim HY; Cho ML
Arthritis Res Ther; 2012 Nov; 14(6):R246. PubMed ID: 23148681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
